Symbol: |
GYG2
|
Description: |
glycogenin 2 [Source:HGNC Symbol;Acc:4700]
|
Location: |
ChrX:2746829-2800859[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:221
Gene |
Compound |
Gen_sig |
Exp_pattern |
GYG2 |
1-O-Octadecyl-[(2.fwdarw.5')-3'-C-ethinyl-cytidylyl]-rac-glycerylyl-(3.fwdarw.5')-5-fluoro-2'-deoxyuridine |
0.034 |
Up |
GYG2 |
5-(p-chlorobenzylidene)-3-phenyl-2-[(1-phenyl-3,5- dimethylpyrazol-4-yl)methylidenehydrazono]thiazolidin-4-one |
0.002 |
Up |
GYG2 |
NSC 720141 |
0.013 |
Down |
GYG2 |
NSC 720187 |
0.003 |
Down |
GYG2 |
NSC 720433 |
0.014 |
Up |
GYG2 |
NSC 720794 |
0.022 |
Up |
GYG2 |
NSC 721533 |
0.034 |
Up |
GYG2 |
NSC 721875 |
0.011 |
Down |
GYG2 |
2-fluorphenylhydrazone alpha-lapachone |
0.03 |
Up |
GYG2 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.028 |
Up |
GYG2 |
6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.008 |
Up |
GYG2 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.008 |
Up |
GYG2 |
Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-propylamino}ethane Bis(trifluoroacetate |
0.006 |
Up |
GYG2 |
2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide |
0.047 |
Up |
GYG2 |
Dasatinib |
0.017 |
Up |
Expression pattern: Sensitivity / Resistance
Total:15 Current:13
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:18
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:18
Total:2 Current:1
[First] [Prev]  Next Last 
|